Page last updated: 2024-10-21

urea and Guillain-Barre Syndrome

urea has been researched along with Guillain-Barre Syndrome in 1 studies

pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.

Guillain-Barre Syndrome: An acute inflammatory autoimmune neuritis caused by T cell- mediated cellular immune response directed towards peripheral myelin. Demyelination occurs in peripheral nerves and nerve roots. The process is often preceded by a viral or bacterial infection, surgery, immunization, lymphoma, or exposure to toxins. Common clinical manifestations include progressive weakness, loss of sensation, and loss of deep tendon reflexes. Weakness of respiratory muscles and autonomic dysfunction may occur. (From Adams et al., Principles of Neurology, 6th ed, pp1312-1314)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kamei, A1
Akasaka, M1
Araya, N1
Ishikawa, K1
Takada, A1
Furukawa, H1
Tanifuji, S1
Asami, M1
Nasu, Y1
Oyama, K1
Chida, S1

Other Studies

1 other study available for urea and Guillain-Barre Syndrome

ArticleYear
Successful Management of Fulminant Guillain-Barré Syndrome and Its Complications.
    Pediatric emergency care, 2018, Volume: 34, Issue:5

    Topics: Adrenergic beta-Antagonists; Child, Preschool; Female; Glucocorticoids; Guillain-Barre Syndrome; Hum

2018